This became apparent during the opening speech at the EFIB 2016, the European Forum for Industrial Biotechnology, in Glasgow. Joanna Dupont-Inglis, director of EuropaBio, began her address with a reference to Glasgow, a city built on coal and steel. In the 21st century, however, the city and its surrounding areas are more geared towards new technologies. And rightfully so, relatively new technologies, such as industrial biotech, are far more likely to grow and prosper than the ‘old’ economy. According to figures, provided by Europabio, this sector currently adds 31,6 billion euro to the European economy. In 2030, this figure will be doubled or even tripled (almost), providing work for a highly-qualified work force between 900.000 and 1.5 billion people.
About the author
Agro & Chemistry is the leading media platform for the biobased and circular economy in the Netherlands and Flanders. Our editors highlights the developments in the BBE.
DSM and ASR to accelerate growth of Biotech Campus Delft
DSM and ASR Dutch Science Park Fund are joining hands to further develop the Biotech Campus…
Editorial office Delft
Belgian biotech remains in Europe’s top three
Measured by market value, Belgium remains a front runner in the European biotech landscape. Only Denmark…
Editorial office Ghent
Chinese industrial biotechsector booming
The Chinese industrial biotechsector is set to grow at a 20 per cent rate per annum.…
Editorial office China
Comments 0 Login to reply to this article. Don't have an account? Register now!